Citations

Clear

77 citation(s) found for "Bilgin, C".

Imaging beyond the Vessel Label in MeVO Thrombectomy: Early Career Perspective
Bilgin, Cem , Kallmes, D, Kallmes, David F , Bilgin, Cem , Kallmes, David F.

Mayo Clinic

Radiology | May 26, 2026 | Volume: 319 | Issue: 2 | Pages: No page available

10.1148/radiol.261240 | PMID 42188735 Get It

Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated Melanoma
Bilgin, Gokce Belge , Nikanpour, Yalda , Kipp, Benjamin R. , Zahrieh, David M. , Block, Matthew S. , Stoff, Ronen , Geiersbach, Katherine B. , Johnson, Geoffrey B. , Markovic, Svetomir N.

Mayo Clinic

International Journal of Cancer | April 21, 2026 | Volume: 159 | Issue: 4 | Pages: 1068-1078

10.1002/ijc.70514 | PMID 42011804 Get It

ABSTRACT Circulating tumor DNA (ctDNA) as a liquid biopsy is an emerging tool used for diagnosis and disease monitoring, yet not all tumors shed DNA equally, thus currently limiting the clinical applicability of this tool. Our institution has developed and validated a droplet digital Polymerase Chain Reaction (ddPCR) ctDNA test for BRAF V600 mutation. We collected data on all BRAF mutated melanoma patients tested with the ddPCR BRAF assay at our institution over the years 2018–2024 and correlated the test results with clinical and radiological baseline parameters, with a focus on Positron Emission Tomography‐Computed Tomography (PET‐CT) data, incorporating both location of lesions and volume of disease. Linear and logistic regression modelling was used to assess possible associations between the baseline parameters and the ctDNA results. We identified 71 BRAF mutated melanoma patients, of which 65 had active disease on imaging studies and 43 had PET‐CT data available for analysis. Multivariate modelling has shown that patients were more likely to have a positive ctDNA result if they had elevated serum lactate dehydrogenase (LDH) (OR = 9.9), had a higher number of lesions on imaging studies (> 10 lesions: OR = 11.3), and if they were younger than 65 (OR = 11.8), with an AUC of 0.84. The PET‐CT calculated total metabolic tumor volume correlated with the quantitative ctDNA result with a Pearson r factor of 0.49. In conclusion, ctDNA ddPCR BRAF testing is easily obtained and might be especially beneficial for patients diagnosed with a clinically aggressive disease, based on elevated LDH, higher PET‐CT metabolic tumor volume, and younger age.
Mechanical thrombectomy versus medical management for pediatric ischemic stroke: a systematic review and meta-analysis of comparative studies
Elek, Alperen , Bilgin, Cem , Ghozy, Sherief, Kadirvel, Ramanathan , Brinjikji, Waleed, Kallmes, David F, Ghozy, Sherief , Ghozy, Sherief , Brinjikji, Waleed , Bilgin, Cem , Brinjikji, Waleed , Kallmes, David F.

Mayo Clinic

Journal of NeuroInterventional Surgery | February 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: jnis-2025-024619

10.1136/jnis-2025-024619 | PMID 41708327 Get It

Background Ischemic stroke is an important cause of morbidity and mortality in children, yet no clinical trials have evaluated mechanical thrombectomy (MT) in this population. Consequently, in contrast to adults, pediatric MT remains an off-label intervention. This meta-analysis aimed to assess its safety and efficacy and compare outcomes with medical management (MM). Methods MEDLINE, Scopus, and Web of Science were searched to identify original studies reporting outcomes of MT, with or without intravenous thrombolysis (IVT) in pediatric ischemic stroke. In studies that concurrently reported MT±IVT and MM±IVT within the same study, outcomes from the MM arms were also extracted for comparative analysis. Results Eighteen studies encompassing 612 pediatric patients were included. The pooled successful recanalization rate (thrombolysis in cerebral infarction (TICI) 2b–3) after mechanical thrombectomy was 88.9% (95% confidence interval (CI) 85.65 to 92.06), and 43.9% (95% CI, 38.67 to 49.09) achieved complete recanalization (TICI 3). Favorable functional outcomes (modified Rankin Scale (mRS) 0–2) occurred in 78.6% (95% CI, 69.58 to 87.61) of patients, with mortality and symptomatic intracranial hemorrhage (sICH) rates of 3.9% (95% CI, 1.88 to 5.92) and 1.3% (95% CI, 1.07 to 2.58), respectively. Shift analysis demonstrated a significant overall improvement in functional outcomes with MT±IVT compared with MM±IVT (common (OR), 0.43; 95% CI, 0.30 to 0.63; P<0.001). Conclusion Our findings suggest that MT has a favorable safety and efficacy profile, resulting in a more favorable mRS shift compared with MM in pediatric ischemic stroke. Further research is needed to identify the pediatric stroke patients who are likely to benefit from MT.
Burden of Central Nervous System Cancer in the United States, 1990-2021
Collaborators, GBD 2021 US CNS Cancer, Han, Hyun Jin , Kim, Yun Seo , Park, Seoyeon , Shin, Jae Il , Kim, Min Seo , Areda, Demelash, Tork, Mohammad Amin Bayat , Bilgin, Gokce Belge , Chennapragada, Suma Sri , Dean, Frances , Deekonda, Sindhura, Ding, Xueting, E’mar, Abdel Rahman, Elhadi, Muhammed, Fazeli, Patrick , Fisher, James L. , Fotouhi, Maryam , Gholamrezanezhad, Ali , Ida, Fidelia , Jani, Chinmay , Kalani, Rizwan , Kazemi, Foad , Keshwani, Ariz, Khosla, Atulya Aman , Lim, Stephen S , Murray, Christopher J L , Naik, Gurudatta , Nguyen, Dang Tuan , Penberthy, Louise, Pestell, Richard G. , Prabhu, Disha , Ramasamy, Shakthi Kumaran, Sabet, Cameron John, Şenol, Yiğit Can , Sham, Sunder, Solanki, Ranjan , Tanwar, Manoj , Amirikah, Mike Tuffour, Verma, Anjul, Yon, Dong Keon, Yon, Dong Keon , Shin, Jae I L , Senol, Yigit Can , Collaborators, GBD 2021 US CNS Cancer, Moon, Ju Hyung , Kim, Yong Bae , Ababneh, Hazim , Abu‐Zaid, Ahmed , Arul, Santhosh , Azzam, Ahmed Y , Bardhan, Mainak , Behnam, Babak , Bhardwaj, Prarthna V , Bhuyan, Soumitra Sudip , Lomer, Nima Broomand , Chen, Mengxuan , Dai, Xiaochen , Doshi, Ojas Prakashbhai , Fares, Jawad , Iwu, Chidozie Declan , Jalloh, Mohamed, Kankam, Samuel Berchi , Mehboob, Riffat , Meštrović, Tomislav , Mokdad, Ali H. , Natto, Zuhair S. , Nguyen, Dang, Nugen, Fred , Orscelik, Atakan , Parikh, Romil R , Puvvula, Jagadeesh , Ramasamy, Shakthi Kumaran, Sabet, Cameron John , Schumacher, Austin E , Sherchan, Samendra , Simegn, Gizeaddis Lamesgin , Singh, Jasvinder A. , Srichawla, Bahadar Singh , Taiba, Jabeen , Yunusa, Ismaeel , Zheng, David X. , Park, Keun Young

Mayo Clinic

JAMA Neurology | November 3, 2025 | Volume: 83 | Issue: 1 | Pages: 35

10.1001/jamaneurol.2025.4286 | PMID 41182787 Get It

Importance Primary brain and central nervous system cancer (collectively referred to as CNS cancer) comprises 2% of all human cancers and poses significant health and economic challenges in the United States. Objective To analyze CNS cancer burden in the US, stratified by time, location (state and division), sex, age group, and Sociodemographic Index (SDI). Design, Setting, and Participants This cross-sectional study involved a repeated analysis of Global Burden of Disease Study (GBD) 2021 data in 2024. Using data from 183 sources, CNS cancer metrics in the US were estimated across states and years. US CNS cancer metrics across all sexes and age groups were included in the GBD. Exposure CNS cancer diagnosis. Main Outcomes and Measures Overall and age-standardized estimates of the incidence, prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost, and years lived with disability per 100 000 population, including 95% uncertainty intervals (UIs), and time trends. Results In 2021, for all age groups and sexes across the US, there were 31 780 incident cases (95% UI, 29971.1 to 32843.9). Age-standardized incidence, DALYs, and mortality rates per 100 000 population were 6.91 (95% UI, 6.58 to 7.12), 134.38 (95% UI, 129.83 to 137.95), and 4.1 (95% UI, 3.87 to 4.22), respectively. Despite no significant change observed in the overall incidence between 1990 and 2021, DALY and mortality rates decreased by 15.77% (95% UI, −17.75% to −13.68%) and 8.41% (95% UI, −11.09% to −6.22%), respectively. Substantial geographic variability was noted. Mississippi, Alabama, Kentucky, and Kansas (West North Central and East South Central divisions) and West Virginia faced persistently high burdens over the past 30 years. Sex differences were evident; disease burden was consistently higher in males compared with females. Age-specific estimates showed a bimodal distribution: the youngest group (&amp;lt;5 years) showed a significant decrease in incidence rate (−34.42% to −11.56%), whereas older age groups (&amp;gt;70 years) experienced increasing trends. DALYs and mortality rates were negatively correlated with SDI (ρ = −0.6860 and ρ = −0.6391; P &amp;lt; .001). Conclusions and Relevance These findings provide valuable insights into the CNS cancer burden across the US by age, sex, location, and SDI, enabling better public health status assessments, health care policy restructuring, and resource redistribution for improved care.
Evaluating a calcium chloride–elastase combination for creating large aneurysms in the endovascular rabbit elastase model
Bilgin, Cem , Bayraktar, Esref Alperen , Ding, Yonghong , Hajj, G El , Oliver, Alexander A , Şenol, Yiğit Can , Kallmes, David F. , Kadirvel, Ramanathan , Ding, Yong-Hong , El Hajj, Gerard , Senol, Yigit Can , Bayraktar, Esref Alperen , Oliver, Alexander A , Bilgin, Cem

Mayo Clinic

Interventional Neuroradiology | October 25, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251390598 | PMID 41138264 Get It

Purpose Large aneurysms have a higher rupture risk, yet no available in vivo animal model consistently produces large aneurysms for testing endovascular therapies. Recent research suggests that adding calcium chloride (CaCl 2 ) to elastase yields larger aneurysms in a surgical rabbit model. We evaluated whether this effect translates to an endovascular approach by comparing aneurysm sizes created using elastase alone versus a CaCl 2 –elastase combination. Methods Aneurysms were created in the right common carotid artery of New Zealand rabbits. One group received 1 mL porcine elastase; the other received elastase plus 0.055 g CaCl 2 (0.5 M). After four weeks, patency was confirmed via digital subtraction angiography. Two blinded co-authors measured the neck, width, and height of the aneurysms. Aneurysm volumes were estimated using AngioCalc.com. Statistical analyses were performed using either the Mann–Whitney U -test or t -test based on data distribution. Results Twenty-nine (29) New Zealand rabbits were included in the study: six in the CaCl 2 and elastase groups, 23 in the elastase-alone group. All induced aneurysms remained patent at follow-up. Mean neck size was significantly larger in the CaCl 2 + elastase group than in the elastase-alone group (4.4 ± 1.1 mm vs 3.5 ± 0.95 mm; respectively, p = 0.02). Differences in width (4.1 ± 0.92 mm vs 3.4 ± 0.36 mm; p = 0.06), height (9.0 ± 1.1 mm vs 9.1 ± 2.1 mm; p = 0.46), and volume (83.5 ± 38.35 mm ³ vs 53.0 ± 16.94 mm³; p = 0.11) were not significant between CaCl 2 + elastase and elastase-alone, respectively. Conclusions CaCl 2 modestly increased neck size but did not significantly enlarge overall aneurysm dimensions. Further studies are needed to assess its utility in endovascular aneurysm models.
Machine learning modeling for outcome prediction of hospitalized patients with aneurysmal subarachnoid hemorrhage
Jabal, Mohamed Sobhi , Wahood, Waseem , Zreik, Jad, Bilgin, Cem , Essibayi, Muhammed Amir , Kobeissi, Hassan , Rinaldo, Lorenzo , Kallmes, David F. , Lanzino, Giuseppe, Brinjikji, Waleed , Ibrahim, Mohamed K. , Essibayi, Muhammed Amir , Kobeissi, Hassan , Kallmes, David F , Bilgin, Cem

Mayo Clinic

Interventional Neuroradiology | September 15, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251375529 | PMID 40953192 Get It

Purpose Aneurysmal rupture and subarachnoid hemorrhage (SAH) have an exceptionally high mortality and morbidity burden. The aim of this study was to develop interpretable machine learning models for predicting short-term poor outcomes defined by the National Inpatient Sample Subarachnoid Hemorrhage Outcome Measure (NIS-SOM). Methods The National Inpatient Sample (NIS) database was queried from 2008 to 2018 to identify patients diagnosed with SAH who had undergone endovascular coiling or clipping for intracranial aneurysm. Demographic, comorbidity, risk factor, and hospital characteristic variables were recorded. Variables were preprocessed, and the feature space was reduced to include the most important features. To predict poor outcomes, machine learning models were trained and cross-validated before being evaluated on a separate testing set. Shapley Additive exPlanations of the best performing model was used for general and local model interpretation. Results Among 18,149 admissions (mean age 55 ± 14 years, 68.8% women), 52.9% had a poor outcome. Test-set AUCs ranged 0.74–0.80; a multilayer perceptron performed best (AUC 0.80, precision 0.74, recall 0.82). SHAP ranked the ten most influential variables: age, neurological comorbidity, paralysis, Medicare insurance, smoking status, Elixhauser burden, fluid-electrolyte disorders, weight loss, arrhythmia, and heart failure. Conclusions The modeling predicted nationwide aSAH prognosis with decent accuracy and highlighted clinical, socioeconomic, and system-level drivers of determinants of poor short-term outcome. These results support the potential of explainable ML tools as complementary tools for early risk stratification, guiding resource allocation, and informing prospective multi-center validation and implementation studies.
E-106 The effects of admission hyperglycemia and diabetes mellitus on mechanical thrombectomy outcomes: a systematic review and meta-analysis
Bilgin, Cem , Bilgin, G Belge, Jabal, Mohamed Sobhi , Kobeissi, H, Kadirvel, Ramanathan , Brinjikji, W, Kallmes, D, Rabinstein, A, Ghozy, Sherief , Senol, Y, Orscelik, Atakan , Brinjikji, W, Kallmes, David F.

Mayo Clinic

SNIS 22nd annual meeting electronic poster abstracts | July 14, 2025 | Volume: No volume available | Issue: No issue available | Pages: A163.1-A163

10.1136/jnis-2025-snis.222 Get It

E-033 Cerebrospinal fluid-venous leak embolization in swine: a novel animal model
Cortese, Jonathan, Bilgin, Cem , Kadirvel, Ramanathan , Kallmes, D, Brinjikji, W, Bayraktar, E, Cortese, Jonathan , Ognard, Julien , Hajj, G El , Brinjikji, W

Mayo Clinic

SNIS 22nd annual meeting electronic poster abstracts | July 14, 2025 | Volume: No volume available | Issue: No issue available | Pages: A112-A113

10.1136/jnis-2025-snis.149 Get It

I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CT
Bilgin, Cem , Bilgin, Gokce Belge , Dundar, Bilge , Kapplinger, Jamie D., Bogsrud, Trond Velde , Durski, Jolanta M. , Hallanger Johnson, Julie E, Hallanger‐Johnson, Julie

Mayo Clinic

Clinical Nuclear Medicine | July 1, 2025 | Volume: 50 | Issue: 10 | Pages: 958-959

10.1097/rlu.0000000000005923 | PMID 40590084 Get It

Radioiodine ablation therapy is commonly used for patients with well-differentiated thyroid cancer. False-positive radioiodine uptake in benign cystic lesions on post-therapy SPECT/CT presents a recognized diagnostic challenge. Here, we present the case of a 33-year-old woman who underwent total thyroidectomy, followed by I-131 radioiodine therapy. Her post–I-131 therapy SPECT/CT revealed incidental radioiodine uptake in a diaphragmatic mesothelial cyst, prompting further investigation. She subsequently underwent a dedicated liver MRI and excision biopsy, both of which were negative for thyroid cancer metastasis. This case highlights the importance of identifying benign sources of radioiodine uptake to avoid unnecessary interventions.
Simulation of cerebrospinal fluid (CSF)-venous fistula embolization in a swine model: A technical video
Bayraktar, Esref Alperen , Cortese, Jonathan, Ognard, Julien , Hajj, G El , Bilgin, Cem , Kadirvel, Ramanathan , Kallmes, David F. , Brinjikji, Waleed , El Hajj, Gerard , Bayraktar, Esref Alperen , Ognard, Julien , Cortese, Jonathan , Bilgin, Cem

Mayo Clinic

Interventional Neuroradiology | June 18, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251349656 | PMID 40530427 Get It

Cerebrospinal fluid venous fistulas (CSFVF) can lead to spontaneous intracranial hypotension, causing debilitating symptoms in patients. The transvenous embolization technique has been developed to occlude leakage sites via an endovascular approach. However, the spinal venous anatomy remains relatively unfamiliar to many neurointerventionalists. This technical video presents a swine model designed to train physicians in navigating the spinal venous system, performing embolization injections, observing their spread, and testing new embolization systems for treating CSFVF. Although there are slight anatomical differences, the spinal venous system in swine closely resembles that of humans, including its navigability and employing liquid embolic agents. We successfully embolized multilevel spinal vasculature that can potentially drain into a fistula formation, without any complications.